C Boaziz

499 total citations
20 papers, 382 citations indexed

About

C Boaziz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, C Boaziz has authored 20 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in C Boaziz's work include Neuroendocrine Tumor Research Advances (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). C Boaziz is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). C Boaziz collaborates with scholars based in France, Gibraltar and Canada. C Boaziz's co-authors include Emmanuel Achille, Jean‐François Morère, Thierry André, N. Tubiana-Mathieu, Arnaud Boutan-Laroze, M. Flesch, Aimery de Gramont, Nicolas Colbert, Pascal Piedbois and Olivier Bouché and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

C Boaziz

19 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Boaziz France	8	326	118	90	75	41	20	382
Javier Sastre Valera Spain	6	288 0.9×	126 1.1×	49 0.5×	82 1.1×	27 0.7×	15	348
Robert Goslin United States	5	306 0.9×	111 0.9×	75 0.8×	126 1.7×	49 1.2×	5	411
B. Massuti Sureda Spain	5	263 0.8×	125 1.1×	47 0.5×	46 0.6×	15 0.4×	26	350
Tad J. Wieczorek United States	11	129 0.4×	146 1.2×	99 1.1×	191 2.5×	50 1.2×	23	480
Timothy Spiro United States	10	151 0.5×	100 0.8×	40 0.4×	66 0.9×	41 1.0×	22	308
Geoff Chong Australia	9	274 0.8×	117 1.0×	111 1.2×	105 1.4×	13 0.3×	25	414
Masafumi Tanaka Japan	8	298 0.9×	118 1.0×	131 1.5×	140 1.9×	14 0.3×	31	421
Naoya Matoba Japan	9	148 0.5×	57 0.5×	57 0.6×	100 1.3×	64 1.6×	24	338
Maria Antista Italy	10	205 0.6×	94 0.8×	57 0.6×	69 0.9×	31 0.8×	26	300
Sandra Beare United Kingdom	9	200 0.6×	109 0.9×	42 0.5×	170 2.3×	23 0.6×	11	372

Countries citing papers authored by C Boaziz

Since Specialization

Citations

This map shows the geographic impact of C Boaziz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Boaziz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Boaziz more than expected).

Fields of papers citing papers by C Boaziz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Boaziz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Boaziz. The network helps show where C Boaziz may publish in the future.

Co-authorship network of co-authors of C Boaziz

This figure shows the co-authorship network connecting the top 25 collaborators of C Boaziz. A scholar is included among the top collaborators of C Boaziz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Boaziz. C Boaziz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC*. Bulletin du Cancer. 93(2). 5–9. 1 indexed citations

André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). [Adjuvant treatment of colon cancer MOSAIC study's main results].. PubMed. 93 Suppl 1. S5–9. 36 indexed citations

Bouillet, T., C Boaziz, Sophie Piperno‐Neumann, et al.. (2004). Phase II Study of Paclitaxel Combined With Vinorelbine in Patients With Advanced Breast Cancer. American Journal of Clinical Oncology. 27(3). 317–321. 6 indexed citations

André, Thierry, Philippe Colin, Christophe Louvet, et al.. (2003). Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial. Journal of Clinical Oncology. 21(15). 2896–2903. 185 indexed citations

André, Thierry, P. Colin, Érick Gamelin, et al.. (2001). Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results. Seminars in Oncology. 28(1 Suppl 1). 35–40. 17 indexed citations

Girard, Timothy D., et al.. (2000). Favorable outcome of gemcitabine-induced respiratory distress syndrome.. PubMed. 151(4). 306–8. 4 indexed citations

Morère, Jean‐François, et al.. (1997). Vinorelbine and ifosfamide for unresectable non-small cell lung cancer. Lung Cancer. 18(1). 95–100. 4 indexed citations

Bouillet, T., et al.. (1997). Chimiothérapie d'induction suivie d'une association concomitante de radiothérapie et de chimiothérapie pour les carcinomes bronchiques non à petites cellules de stade III. Cancer/Radiothérapie. 1(2). 121–131. 3 indexed citations

Tourani, J.M., Virginie Lucas, Didier Mayeur, et al.. (1996). Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Annals of Oncology. 7(5). 525–528. 28 indexed citations

10.

Bérenger, Nathalie, et al.. (1996). Somatostatin receptor imaging in small cell lung cancer. European Journal of Cancer. 32(8). 1429–1431. 23 indexed citations

11.

Raymond, Éric, et al.. (1996). Logistic regression model of fotemustine toxicity combining independent phase II studies. Cancer. 78(9). 1980–1987. 13 indexed citations

12.

Moretti, Jean‐Luc, Meltem Çağlar, C Boaziz, Nadine Caillat‐Vigneron, & Jean‐François Morère. (1995). Sequential functional imaging with technetium-99m hexakis-2-meth oxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?. European Journal of Nuclear Medicine and Molecular Imaging. 22(2). 177–180. 32 indexed citations

13.

Morère, Jean‐François, et al.. (1994). Cisplatin—5-fluorouracil in small cell lung cancer. A Phase II study in 109 patients. Lung Cancer. 11(3-4). 275–281. 8 indexed citations

14.

Morère, Jean‐François, et al.. (1993). [Infectious complications during treatments with interleukin-2].. PubMed. 22(9). 413–6. 1 indexed citations

15.

Raymond, Éric, et al.. (1993). [Cancer of the kidney: changes in blood lymphocyte subsets induced by treatment with interferon alpha-2b and interleukin-2r].. PubMed. 80(4). 299–309. 2 indexed citations

16.

Boaziz, C, et al.. (1993). [Malignant melanoma of the uvea].. PubMed. 80(7). 577–83. 3 indexed citations

17.

Boaziz, C. (1991). [Metastasis of renal cancer].. PubMed. 25(6-7). 275–82. 2 indexed citations

18.

Boaziz, C, et al.. (1991). [Brain metastases of malignant melanomas].. PubMed. 78(4). 347–53. 7 indexed citations

19.

Boaziz, C, et al.. (1991). [Interferon and interleukin 2 in metastatic cancer of the kidney. Apropos of 18 cases].. PubMed. 25(4). 163–7. 1 indexed citations

20.

Boaziz, C, J.L. Breau, Jean‐François Morère, & Liron L. Israel. (1991). [The blood-brain barrier: implications for chemotherapy in brain tumors].. PubMed. 39(8). 789–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact